Table of Contents
Influenza Research and Treatment
Volume 2013 (2013), Article ID 645348, 9 pages
http://dx.doi.org/10.1155/2013/645348
Research Article

3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target

Bioinformatics & Medical Informatics Team, Biomedical Research Foundation, Academy of Athens, Soranou Efessiou 4, 11527 Athens, Greece

Received 5 June 2013; Revised 18 July 2013; Accepted 11 August 2013

Academic Editor: Prasert Auewarakul

Copyright © 2013 Dimitrios Vlachakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Parry, “H7N9 virus is more transmissible and harder to detect than H5N1, say experts,” British Medical Journal, vol. 346, Article ID f2568, 2013. View at Publisher · View at Google Scholar
  2. J. Parry, “H7N9 avian flu infects humans for the first time,” British Medical Journal, vol. 346, Article ID f2151, 2013. View at Google Scholar
  3. CDC, H7N9: Frequently Asked Questions, 2013.
  4. J. Holland, K. Spindler, and F. Horodyski, “Rapid evolution of RNA genomes,” Science, vol. 215, no. 4540, pp. 1577–1585, 1982. View at Google Scholar · View at Scopus
  5. C. Li, M. Hatta, S. Watanabe, G. Neumann, and Y. Kawaoka, “Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses,” Journal of Virology, vol. 82, no. 23, pp. 11880–11888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. G. Arzey, P. D. Kirkland, K. E. Arzey et al., “Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia,” Emerging Infectious Diseases, vol. 18, no. 5, pp. 814–816, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Huang, A. R. Wang, Z. H. Liu et al., “Seroprevalence of avian influenza H9N2 among poultry workers in Shandong Province, China,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 32, no. 10, pp. 1347–1351, 2013. View at Publisher · View at Google Scholar
  8. M. Hirst, C. R. Astell, M. Griffith et al., “Novel avian influenza H7N3 strain outbreak, British Columbia,” Emerging Infectious Diseases, vol. 10, no. 12, pp. 2192–2195, 2004. View at Google Scholar · View at Scopus
  9. G. I. Shapiro, T. Gurney Jr., and R. M. Krug, “Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs,” Journal of Virology, vol. 61, no. 3, pp. 764–773, 1987. View at Google Scholar · View at Scopus
  10. J. S. Nguyen-Van-Tam, P. Nair, P. Acheson et al., “Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis,” Eurosurveillance, vol. 11, no. 5, Article ID E060504.2, 2006. View at Google Scholar · View at Scopus
  11. “Avian influenza A/(H7N2) outbreak in the United Kingdom,” Eurosurveillance, vol. 12, no. 22, 2007.
  12. R. A. M. Fouchier, P. M. Schneeberger, F. W. Rozendaal et al., “Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 5, pp. 1356–1361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Y. Kwon, S. S. Lee, C. Y. Kim, J. Y. Shin, S. Y. Sunwoo, and Y. S. Lyoo, “Genetic characterization of H7N2 influenza virus isolated from pigs,” Veterinary Microbiology, vol. 153, no. 3-4, pp. 393–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Z. Shi, G. H. Deng, P. H. Liu et al., “Isolation and characterization of H7N9 viruses from live poultry,” Chinese Science Bulletin, vol. 58, no. 16, pp. 1857–1863, 2013. View at Google Scholar
  15. Y. Chen, W. Liang, S. Yang et al., “Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome,” The Lancet, vol. 381, no. 9881, pp. 1916–1925, 2013. View at Google Scholar
  16. J. Li, X. Yu, X. Pu et al., “Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human,” Science China Life Sciences, vol. 56, no. 6, pp. 485–492, 2013. View at Google Scholar
  17. R. Gao, B. Cao, Y. Hu et al., “Human infection with a novel avian-origin influenza A, (H7N9) virus,” The New England Journal of Medicine, vol. 368, pp. 1888–1897, 2013. View at Google Scholar
  18. M. V. Ranst and P. Lemey, “Genesis of avian-origin H7N9 influenza A viruses,” The Lancet, vol. 381, no. 9881, pp. 1883–1885, 2013. View at Publisher · View at Google Scholar
  19. T. Kageyama, S. Fujisaki, E. Takashita et al., “Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China,” Eurosurveillance, vol. 18, no. 15, Article ID 20453, 2013. View at Google Scholar
  20. M. D. De Jong, T. T. Thanh, T. H. Khanh et al., “Oseltamivir resistance during treatment of influenza A (H5N1) infection,” The New England Journal of Medicine, vol. 353, no. 25, pp. 2667–2672, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Malik Peiris, M. D. de Jong, and Y. Guan, “Avian influenza virus (H5N1): a threat to human health,” Clinical Microbiology Reviews, vol. 20, no. 2, pp. 243–267, 2007. View at Publisher · View at Google Scholar
  22. R. J. Russell, L. F. Haire, D. J. Stevens et al., “The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design,” Nature, vol. 443, no. 7107, pp. 45–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. von Itzstein, “The war against influenza: discovery and development of sialidase inhibitors,” Nature Reviews Drug Discovery, vol. 6, no. 12, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Ghedin, E. C. Holmes, J. V. DePasse et al., “Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission,” The Journal of Infectious Diseases, vol. 206, no. 10, pp. 1504–1511, 2012. View at Publisher · View at Google Scholar
  25. J. K. Taubenberger, A. H. Reid, R. M. Lourens, R. Wang, G. Jin, and T. G. Fanning, “Characterization of the 1918 influenza virus polymerase genes,” Nature, vol. 437, no. 7060, pp. 889–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Obayashi, H. Yoshida, F. Kawai et al., “The structural basis for an essential subunit interaction in influenza virus RNA polymerase,” Nature, vol. 454, no. 7208, pp. 1127–1131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Elhefnawi, O. Alaidi, N. Mohamed et al., “Identification of novel conserved functional motifs across most Influenza A viral strains,” Virology Journal, vol. 8, article 44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. T. Heiny, O. Miotto, K. N. Srinivasan et al., “Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets,” PLoS ONE, vol. 2, no. 11, Article ID e1190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Honda and A. Ishihama, “The molecular anatomy of influenza virus RNA polymerase,” Biological Chemistry, vol. 378, no. 6, pp. 483–488, 1997. View at Google Scholar · View at Scopus
  30. K. Das, J. M. Aramini, L.-C. Ma, R. M. Krug, and E. Arnold, “Structures of influenza A proteins and insights into antiviral drug targets,” Nature Structural and Molecular Biology, vol. 17, no. 5, pp. 530–538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Benson, I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, and D. L. Wheeler, “GenBank,” Nucleic Acids Research, vol. 35, no. 1, pp. D21–D25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. D. Thompson, D. G. Higgins, and T. J. Gibson, “CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Research, vol. 22, no. 22, pp. 4673–4680, 1994. View at Google Scholar · View at Scopus
  34. S. R. Eddy, “Multiple alignment using hidden Markov models,” in Proceedings of the International Conference on Intelligent Systems for Molecular Biology, vol. 3, pp. 114–120, 1995.
  35. A. Sali, L. Potterton, F. Yuan, H. Van Vlijmen, and M. Karplus, “Evaluation of comparative protein modeling by MODELLER,” Proteins, vol. 23, no. 3, pp. 318–326, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. W. L. DeLano, The PyMOL User's Manual, DeLano Scientific, San Carlos, Calif, USA, 2002.
  37. Y. Duan, C. Wu, S. Chowdhury et al., “A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations,” Journal of Computational Chemistry, vol. 24, no. 16, pp. 1999–2012, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Hess, C. Kutzner, D. Van Der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Sellis, D. Vlachakis, and M. Vlassi, “Gromita: a fully integrated graphical user interface to gromacs 4,” Bioinformatics and Biology Insights, vol. 3, pp. 99–102, 2009. View at Google Scholar
  40. R. A. Laskowski, J. A. C. Rullmann, M. W. MacArthur, R. Kaptein, and J. M. Thornton, “AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR,” Journal of Biomolecular NMR, vol. 8, no. 4, pp. 477–486, 1996. View at Google Scholar · View at Scopus
  41. D. Eisenberg, R. Lüthy, and J. U. Bowie, “VERIFY3D: assessment of protein models with three-dimensional profiles,” Methods in Enzymology, vol. 277, pp. 396–406, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Li, R. Chen, and Z. Weng, “RDOCK: refinement of rigid-body protein docking predictions,” Proteins, vol. 53, no. 3, pp. 693–707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. J. Sanz-Ezquerro, T. Zürcher, S. De La Luna, J. Ortín, and A. Nieto, “The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis,” Journal of Virology, vol. 70, no. 3, pp. 1905–1911, 1996. View at Google Scholar · View at Scopus
  44. H. J. Maier, T. Kashiwagi, K. Hara, and G. G. Brownlee, “Differential role of the influenza A virus polymerase PA subunit for vRNA and cRNA promoter binding,” Virology, vol. 370, no. 1, pp. 194–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. L. S. Beese and T. A. Steitz, “Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism,” EMBO Journal, vol. 10, no. 1, pp. 25–33, 1991. View at Google Scholar · View at Scopus
  46. P. Yuan, M. Bartlam, Z. Lou et al., “Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site,” Nature, vol. 458, no. 7240, pp. 909–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Tomassini, H. Selnick, M. E. Davies et al., “Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 12, pp. 2827–2837, 1994. View at Google Scholar · View at Scopus
  48. K. Sugiyama, E. Obayashi, A. Kawaguchi et al., “Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase,” EMBO Journal, vol. 28, no. 12, pp. 1803–1811, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Blass, E. Patzelt, and E. Kuechler, “Identification of the cap binding protein of influenza virus,” Nucleic Acids Research, vol. 10, no. 15, pp. 4803–4812, 1982. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Marcotrigiano, A.-C. Gingras, N. Sonenberg, and S. K. Burley, “Cocrystal structure of the messenger RNA 5' cap-binding protein (elF4E) bound to 7-methyl-GDP,” Cell, vol. 89, no. 6, pp. 951–961, 1997. View at Google Scholar · View at Scopus
  51. F. Tarendeau, T. Crepin, D. Guilligay, R. W. H. Ruigrok, S. Cusack, and D. J. Hart, “Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Rost, R. Schneider, and C. Sander, “Protein fold recognition by prediction-based threading,” Journal of Molecular Biology, vol. 270, no. 3, pp. 471–480, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. M. R. M. Fontes, T. Teh, D. Jan, R. I. Brinkworth, and B. Kobe, “Structural basis for the specificity of bipartite nuclear localization sequence binding by importin-α,” Journal of Biological Chemistry, vol. 278, no. 30, pp. 27981–27987, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Kuzuhara, D. Kise, H. Yoshida et al., “Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue,” Journal of Biological Chemistry, vol. 284, no. 11, pp. 6855–6860, 2009. View at Publisher · View at Google Scholar · View at Scopus